How should India regulate its clinical trial industry?

India's Live Mint takes a long-form look at the country's $1.8 billion clinical trial industry, spotlighting the difficulty regulators have keeping researchers honest, the efforts to better police violations of the law and the governmental infighting spurred by the increasing demand for drug data. Story

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.